# France Hip Implants Market > France Hip Implants Market Research Report By Product Type (Total Hip Replacement Implants, Fixed-Bearing Hip Implants, Mobile-Bearing Total Hip Implants, Partial Hip Replacement Implants, Hip Resurfacing Implants, Revision Hip Replacement Implants), By End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers) andBy Material (Metal-on-Polyethylene, Ceramic-on-Metal, Metal-on-Metal, Ceramic-on-Polyethylene, Ceramic-on-Ceramic) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 3.56% - **2024:** $ 610.68 Million - **2025:** $ 632.42 Million - **2035:** $ 897.32 Million - **Key Players:** Johnson & Johnson (US), Stryker Corporation (US), Zimmer Biomet (US), Smith & Nephew (GB), DePuy Synthes (US), Medtronic (US), B. Braun Melsungen AG (DE), Exactech (US), Wright Medical Group N.V. (NL) **Report ID:** MRFR/MED/49362-HCR · **Pages:** 200 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/france-hip-implants-market-51119 --- ## Market Summary ## **France Hip Implants Market Overview** As per MRFR analysis, the France Hip Implants Market Size was estimated at 442.44 (USD Million) in 2023. The France Hip Implants Market Industry is expected to grow from 458.1(USD Million) in 2024 to 699.6 (USD Million) by 2035. The France Hip Implants Market CAGR (growth rate) is expected to be around 3.924% during the forecast period (2025 - 2035). ### **Key France Hip Implants Market Trends Highlighted** The France Hip Implants Market is witnessing several key trends that are shaping its landscape. The aging population in France is one of the major drivers for the rise in hip implant procedures, as older adults tend to experience more hip joint problems due to osteoarthritis and other degenerative conditions. In response, advancements in surgical techniques and implant materials are facilitating quicker recovery times, enhancing patient outcomes, and increasing the demand for hip implants. Furthermore, minimally invasive surgical methods are gaining traction, offering benefits such as reduced pain and shorter hospital stays, which appeal to both patients and healthcare providers. Market Opportunities include the growing use of 3D printing technology that creates custom implants to suit specific patient anatomy, enhancing their performance. The healthcare system in France fosters innovation and supports custom orthopedic implant manufacturing aimed at providing optimum patient satisfaction and improved medical outcomes. Custom solutions tailored to solve particular patient problems enhance satisfaction and medical outcomes. Furthermore, there is a notable increase in the level of education and awareness around joint health, which prompts more people to consider surgical treatment instead of just medication. In alignment with government policies encouraging active living and preventative healthcare, patients are taking more initiative regarding their joint health, actively seeking out hip replacement surgery when required. The impact of these trends indicates a dynamic evolution in the hip implant market in France, where continuous innovation, a growing patient population, and an increased focus on personalized medical solutions converge. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **France Hip Implants Market Drivers** #### **Aging Population in France** The increasing aging population in France is a significant driver for the France Hip Implants Market Industry. According to the French National Institute of Statistics and Economic Studies, the population aged 65 years and older is projected to rise from approximately 20% of the total population in 2020 to nearly 25% by 2035. This demographic shift means a substantial increase in hip-related health problems, including osteoporosis and fractures, thereby boosting the demand for hip implants. Given that age is a major risk factor for hip injuries and the subsequent need for surgical interventions, this trend presents a robust opportunity for manufacturers and healthcare providers. The French government has recognized this shift and is investing in healthcare infrastructure to cater to the increased demand, which further supports the growth of the France Hip Implants Market. #### **Technological Advancements in Medical Devices** The continuous advancements in medical technology, particularly in hip implant manufacturing, are propelling the France Hip Implants Market Industry forward. Innovative materials, such as enhanced biocompatible alloys and polyethylene, have improved the durability and performance of hip implants. Companies like DePuy Synthes and Stryker are at the forefront of Research and Development (R&D) efforts focused on these innovations. With advancements, the life expectancy of hip implants has increased significantly, reducing the need for revision surgeries. According to the French Biomedical Research Agency, there has been a notable improvement in surgical techniques and postoperative care, resulting in a 15% reduction in surgical complications within the past five years. This elevates the attractiveness of hip implant solutions and encourages higher adoption rates among surgical practitioners and patients alike. #### **Rising Incidence of Hip Disorders** The rising incidence of hip disorders, especially among the elderly population, is a significant factor driving growth in the France Hip Implants Market Industry. Research by healthcare institutions indicates that conditions like osteoarthritis affect about 10% of the population aged 60 years and above in France, leading to an increased requirement for hip replacement surgeries. This prevalence sets a pressing demand for hip implants, which has been observed by healthcare professionals across the country. The French Ministry of Health has also reported a steady increase in orthopedic surgeries in past years, aligning with the growing number of patients suffering from hip-related ailments. This trend not only emphasizes the need for effective treatments but also reinforces the role of implant manufacturers in providing high-quality solutions to improve patient's quality of life. ### **France Hip Implants Market Segment Insights** #### **Hip Implants Market Product Type Insights** The France Hip Implants Market has shown noticeable growth and diversification in terms of Product Type, reflecting advancements in medical technology and increasing demand for enhanced surgical outcomes. Total Hip Replacement Implants remain among the most crucial options within this market, providing a robust solution for patients with severe hip conditions, thereby dominating the landscape. The growing aging population in France, combined with the rising prevalence of osteoarthritis, fuels the demand for such implants. Fixed-Bearing Hip Implants are also significant, known for their stability and durability. Their design often leads to reduced wear over time, making them a popular choice among orthopedic surgeons. Meanwhile, Mobile-Bearing Total Hip Implants offer an improved range of motion and joint stability, which can be especially beneficial for active patients and contribute to faster recovery times. Furthermore, Partial Hip Replacement Implants serve a specialized segment of the market, catering particularly to patients with localized damage often resulting from femoral neck fractures. This option allows for less invasive procedures and quicker recovery, making it attractive to both patients and healthcare providers. Hip Resurfacing Implants represent another trend aimed at younger, more active individuals who seek to delay complete hip replacement. This option is popular for its potential to preserve the femoral head, leading to less bone loss and a more natural hip joint function. Lastly, Revision Hip Replacement Implants cater to patients who require additional surgeries due to complications or wear over time from previous procedures. They signify the response to the growing demands of a more complex patient cohort, thus highlighting the need for more specialized choices in the France Hip Implants Market. Market trends indicate that technological advancements in these segments are continually evolving, with innovations such as patient-specific models and materials that enhance biocompatibility becoming increasingly prevalent. These trends, combined with a supportive governmental health infrastructure focused on orthopedics, create a promising environment for growth within the France Hip Implants Market, meeting the diverse needs of the patient population while addressing the challenges of successful and long-lasting surgical interventions. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review #### **Hip Implants Market End User Insights** The End User segment of the France Hip Implants Market plays a crucial role in shaping the overall industry, comprising key players such as Hospitals, Orthopedic Clinics, and Ambulatory Surgical Centers. Hospitals typically serve as the primary healthcare facilities for hip implant surgeries, benefitting from advanced technology, comprehensive care, and a steady influx of patients requiring joint replacements. On the other hand, Orthopedic Clinics specialize in musculoskeletal disorders, attracting patients who prefer targeted care from specialists, leading to increased demand for hip implants in these specialized settings. Ambulatory Surgical Centers have gained significance due to their cost-efficiency and the convenience they offer for outpatient procedures, making them an appealing choice for patients seeking minimally invasive surgeries. The growth of these facilities aligns with the increasing awareness of surgical options and the need for accessible healthcare solutions in France, influenced by demographic shifts and an aging population. The France Hip Implants Market reflects evolving trends centered around these End Users as they adapt to the changing landscape of orthopedic care and patient needs. #### **Hip Implants Market Material Insights** The France Hip Implants Market has seen significant attention towards its Material segment, which primarily encompasses variations such as Metal-on-Polyethylene, Ceramic-on-Metal, Metal-on-Metal, Ceramic-on-Polyethylene, and Ceramic-on-Ceramic. The noteworthy shift towards these materials reflects advancements in technology and patient outcomes, with a growing preference for options that offer durability and reduced wear. Metal-on-Polyethylene remains popular due to its cost-effectiveness and historical performance. Meanwhile, Ceramic-on-Metal is gaining traction for its lower friction and wear rates, making it a preferred choice for many orthopedic surgeons. Metal-on-Metal designs, although they were once favored for their robustness, face scrutiny due to potential complications, leading to a more cautious approach to selection. Ceramic-on-Polyethylene finds its place through an appealing balance of properties, whereas Ceramic-on-Ceramic designs are touted for their minimal wear and longevity, crucial for patients requiring longer-lasting solutions. These material choices are pivotal in determining the success of hip implant surgeries in France, aligning with the demand for lower complication rates and improved patient satisfaction. Overall, the evolution and preference in materials greatly influence the overall trends within the France Hip Implants Market industry. ### **France Hip Implants Market Key Players and Competitive Insights** The France Hip Implants Market is characterized by a dynamic competitive landscape where various players vie for market share through innovative product offerings and strategic partnerships. This sector has seen a surge in demand due to the growing aging population, increasing prevalence of hip-related disorders, and advancements in surgical technologies. The competitive insights reveal a mix of established brands and emerging companies that are focusing on enhancing their product portfolios and expanding their distribution networks. The market players are increasingly investing in research and development to incorporate cutting-edge materials and techniques into their hip implant solutions, thereby improving outcomes for patients and healthcare providers alike. As these companies innovate and adapt to evolving market demands, competitive strategies are critical for sustaining growth in this vital healthcare segment. B. Braun Melsungen has established a substantial presence in the France Hip Implants Market, leveraging its extensive experience and expertise in surgical instruments and devices. The company is renowned for its commitment to quality and innovation, which is reflected in its range of hip implant products. B. Braun Melsungen excels in offering customizable solutions that cater to the specific needs of orthopedic surgeons and patients, ensuring better surgical outcomes. Its robust distribution network and strong relationships with healthcare providers in France further reinforce its position in the market. The company's investment in local operations, including training for medical professionals and support services, additionally highlights its dedication to enhancing healthcare delivery in the region. By focusing on reliability and precision, B. Braun Melsungen is well-positioned to meet the demands of the French healthcare system. Ottobock also plays a significant role in the France Hip Implants Market, showcasing a diverse portfolio that includes high-quality hip implant systems and advanced orthopedic solutions. The company is known for its innovative approaches and patient-centric products that prioritize both functionality and comfort. Ottobock emphasizes research and development, frequently collaborating with medical professionals to develop new technologies that enhance the surgical process and improve patient recovery experiences. The company has established a reputable market presence through strategic partnerships and collaborations with hospitals and orthopedic clinics, ensuring easy access to its products and services. In recent years, Ottobock has also engaged in several mergers and acquisitions to strengthen its capabilities within the French market, enhancing its product offerings and expanding its influence. By continuously enhancing its technological expertise and maintaining strong relationships with stakeholders, Ottobock remains a formidable competitor in the French hip implants landscape. ### **Key Companies in the France Hip Implants Market Include** ### **France Hip Implants Market Industry Developments** The France Hip Implants Market has recently witnessed significant developments. In September 2023, Zimmer Biomet announced the launch of a new line of hip implants designed using advanced materials for increased durability and patient comfort. Following this, in August 2023, Stryker introduced an innovative surgical technique aimed at reducing recovery times post-hip replacement surgeries. Additionally, Medtronic has been actively expanding its portfolio in this sector, focusing on minimally invasive solutions, a trend that has gained traction in France's healthcare landscape. The market has also seen considerable growth as the demand for hip implants increases due to the rising incidence of hip-related disorders among the aging population in France. Recent reports indicate that the valuation of the France Hip Implants Market is expected to grow steadily over the next few years, driven by advancements in technology and an increasing willingness among patients to undergo surgical interventions. In terms of mergers and acquisitions, no substantial news has emerged recently regarding the companies of interest in the France Hip Implants Market such as B. Braun Melsungen, Ottobock, and Wright Medical. Over the past two to three years, various product recalls, and regulatory approvals have played a role in shaping the landscape, highlighting the importance of compliance and innovation within the industry. ### **France Hip Implants Market Segmentation Insights** #### **Hip Implants Market Product Type Outlook** #### **Hip Implants Market End User Outlook** #### **Hip Implants Market Material Outlook** ## Market Drivers ### Growing Healthcare Expenditure The rising healthcare expenditure in France is a significant driver for the hip implants market. With the French government allocating approximately €200 billion annually to healthcare, there is a concerted effort to improve surgical services and patient care. This financial commitment facilitates access to advanced medical technologies, including hip implants. The hip implants market benefits from this increased funding, as hospitals are more likely to invest in high-quality implants and innovative surgical solutions. Additionally, the trend towards value-based care encourages healthcare providers to adopt effective treatments that enhance patient outcomes, further stimulating market growth. As a result, the hip implants market is poised for expansion, supported by a robust healthcare infrastructure. ### Increased Awareness and Education There is a growing awareness and education regarding hip health among the French population, which is positively impacting the hip implants market. Public health campaigns and educational programs are informing individuals about the importance of early diagnosis and treatment of hip disorders. This heightened awareness is leading to an increase in consultations with orthopedic specialists, resulting in more patients seeking surgical options. The hip implants market is likely to benefit from this trend, as more individuals become proactive about their health. Furthermore, as patients become better informed about the benefits of hip implants, the demand for these products is expected to rise. This shift in patient behavior could potentially lead to a market growth rate of 5% over the next few years. ### Rising Incidence of Hip Disorders The increasing prevalence of hip disorders in France is a primary driver for the hip implants market. Conditions such as osteoarthritis and hip fractures are becoming more common, particularly among the elderly population. According to recent health statistics, approximately 15% of adults aged 60 and above in France experience significant hip-related issues. This trend is likely to escalate as the population ages, leading to a higher demand for hip implants. The hip implants market is responding to this need by innovating and expanding product offerings to cater to a growing patient base. Furthermore, the economic burden associated with untreated hip disorders, estimated at €2 billion annually in healthcare costs, underscores the necessity for effective surgical interventions, thereby propelling the market forward. ### Advancements in Surgical Techniques Innovations in surgical techniques are significantly influencing the hip implants market. Minimally invasive procedures, such as direct anterior approach hip replacement, are gaining traction in France, offering patients reduced recovery times and improved outcomes. These advancements not only enhance patient satisfaction but also increase the efficiency of surgical operations. The hip implants market is witnessing a shift towards these modern techniques, which are supported by ongoing training and education for orthopedic surgeons. As hospitals adopt these advanced methods, the demand for high-quality implants is expected to rise. This trend is reflected in the market, with a projected growth rate of 6% annually over the next five years, driven by the increasing preference for less invasive surgical options. ### Technological Integration in Healthcare The integration of advanced technologies in healthcare is driving the hip implants market in France. Innovations such as 3D printing and computer-assisted surgery are revolutionizing the way hip implants are designed and implanted. These technologies allow for personalized implants that fit patients more accurately, improving surgical outcomes and patient satisfaction. The hip implants market is adapting to these technological advancements, with manufacturers investing in research and development to create cutting-edge products. As hospitals increasingly adopt these technologies, the demand for sophisticated hip implants is expected to grow. This trend indicates a potential market expansion, with projections suggesting a compound annual growth rate of 7% over the next five years, as the industry embraces the future of orthopedic surgery. ## Future Outlook The [Hip Implants Market](https://www.marketresearchfuture.com/reports/hip-implants-market-8448) in France is projected to grow at a 3.56% CAGR from 2025 to 2035, driven by technological advancements, an aging population, and increasing healthcare expenditure. **New opportunities:** - Development of personalized hip implant solutions using 3D printing technology. - Expansion of telehealth services for post-operative care and monitoring. - Strategic partnerships with rehabilitation centers to enhance patient recovery programs. By 2035, the hip implants market is expected to achieve substantial growth, reflecting evolving healthcare needs. ## Segment Insights ### By Product: Total Hip Implants (Largest) vs. Mobile-Bearing Total Hip Implants (Fastest-Growing) The France hip implants market exhibits a significant distribution of shares among various segment values. Total Hip Implants hold the largest share, primarily driven by the increasing prevalence of degenerative joint diseases and the rising aging population. Fixed-Bearing Hip Implants and Partial Hip Implants also contribute notably, catering to a variety of patient needs and preferences in surgical solutions. Growth trends indicate a strong demand for Mobile-Bearing Total Hip Implants, heralded as the fastest-growing segment due to their enhanced mobility and reduced wear rates compared to traditional designs. Factors such as technological advancements in implant materials, increasing awareness about hip surgeries, and rising healthcare expenditure are propelling this segment forward. The development of innovative products is expected to further foster competition and growth within the France hip implants market. Total Hip Implants (Dominant) vs. Revision Hip Implants (Emerging) Total Hip Implants are currently the dominant segment within the France hip implants market, offering comprehensive solutions for total joint replacement in patients with advanced hip conditions. They are preferred for their reliability and extensive clinical success. In contrast, Revision Hip Implants, although considered an emerging segment, play a crucial role in addressing the needs of patients requiring corrective surgeries after initial hip implant failures. They benefit from advanced design innovations that enhance longevity and functionality. As surgical techniques evolve and the number of revision surgeries rises due to older implant types failing, the Revision Hip Implants segment is anticipated to grow significantly, driven by increased surgical interventions and the need for effective solutions to restore mobility. ### By End-User: Hospitals (Largest) vs. Orthopedic Clinics (Fastest-Growing) In the France hip implants market, hospitals dominate the end-user segment, commanding a significant market share due to their comprehensive treatment offerings and advanced surgical facilities. They cater to a large volume of patients and have established networks with orthopedic specialists. Orthopedic clinics, while having a smaller share, are rapidly gaining traction as more patients seek specialized care, leading to a shift in preferences towards outpatient procedures. Growth trends in the end-user segment are driven by an increasing elderly population, rising incidences of hip-related disorders, and advancements in surgical techniques. Additionally, the push towards minimally invasive surgeries is influencing more patients to opt for orthopedic clinics, which are perceived as more accessible and efficient. The combination of technological advancements and an increasing focus on patient convenience is expected to continue fostering growth within this segment. Hospitals (Dominant) vs. Orthopedic Clinics (Emerging) In the end-user segment of the France hip implants market, hospitals hold a dominant position due to their extensive infrastructure, availability of specialized surgeons, and comprehensive healthcare services. They are equipped with advanced technology and facilities that enable complex surgical procedures, thus attracting a high patient volume. Conversely, orthopedic clinics are emerging as a vital alternative, especially for less complex surgeries. These clinics provide focused care and often require shorter recovery times, making them attractive to patients seeking efficient treatment. As the healthcare landscape evolves, orthopedic clinics are likely to expand their market share by enhancing their service offerings and improving patient experiences. ### By Material: Metal-on-Polyethylene (Largest) vs. Ceramic-on-Metal (Fastest-Growing) In the France hip implants market, the segment distribution reveals that Metal-on-Polyethylene holds a significant portion of the market share, making it the predominant choice among patients and healthcare providers. Following closely, Ceramic-on-Metal is gaining traction, currently experiencing rapid adoption trends, indicating a shift in preference toward more modern materials that offer enhanced performance and longevity. Growth trends in this segment are being driven by advancements in implant technology, which lead to improved wear resistance and reduced complications. The increasing aging population and the rising incidence of hip-related ailments have fueled demand for these implants. Moreover, the growing acceptance of innovative materials in orthopedic solutions is projected to accelerate the market dynamics, particularly for Ceramic-on-Metal which is poised for considerable growth over the coming years. Metal-on-Polyethylene (Dominant) vs. Ceramic-on-Metal (Emerging) Metal-on-Polyethylene is recognized as the dominant player in the implants sector, characterized by its balanced performance and reliability, making it the preferred option for many orthopedic surgeons. This combination offers high durability and a satisfactory level of comfort for patients. In contrast, Ceramic-on-Metal represents an emerging segment, praised for its reduced friction and wear rates, which minimize the risk of implant failure. The advancements in manufacturing techniques have further enhanced the properties of Ceramic-on-Metal, positioning it as a competitive alternative. As healthcare providers continue to seek materials that enhance patient outcomes, these two types showcase the ongoing evolution and diversification within the France hip implants market, catering to varied patient needs. ## Competitive Benchmarking The hip implants market in France is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on patient-centric solutions. Key players such as Johnson & Johnson (US), Stryker Corporation (US), and Zimmer Biomet (US) are at the forefront, leveraging their extensive research and development capabilities to introduce advanced products. These companies appear to be strategically positioned to capitalize on the growing demand for minimally invasive surgical options and personalized implants, which are becoming essential in enhancing patient outcomes and satisfaction. Their collective emphasis on innovation and technological advancements is likely to intensify competition, as they strive to differentiate their offerings in a market that is gradually shifting towards more sophisticated solutions.In terms of business tactics, companies are increasingly localizing manufacturing to enhance supply chain efficiency and reduce lead times. This approach not only optimizes operational costs but also aligns with the growing demand for sustainable practices within the healthcare sector. The competitive structure of the market appears moderately fragmented, with several players vying for market share. However, the influence of major companies remains substantial, as they continue to set industry standards and drive technological advancements that smaller firms may struggle to match. In October Stryker Corporation (US) announced the launch of its latest hip implant technology, which incorporates AI-driven analytics to improve surgical precision. This strategic move is significant as it not only enhances the surgical experience but also positions Stryker as a leader in integrating digital solutions into traditional orthopedic practices. The adoption of AI in surgical procedures could potentially lead to better patient outcomes and reduced recovery times, thereby reinforcing Stryker's competitive edge in the market. In September Zimmer Biomet (US) expanded its partnership with a leading French hospital network to develop customized hip implants tailored to the specific needs of patients. This collaboration underscores the importance of localized solutions and patient-centric approaches in the current market. By focusing on customization, Zimmer Biomet is likely to enhance its market presence and foster stronger relationships with healthcare providers, which could translate into increased sales and brand loyalty. In August Johnson & Johnson (US) unveiled a new sustainability initiative aimed at reducing the environmental impact of its manufacturing processes for hip implants. This initiative reflects a broader trend within the industry towards sustainability and responsible manufacturing. By prioritizing eco-friendly practices, Johnson & Johnson not only addresses regulatory pressures but also appeals to a growing segment of environmentally conscious consumers, potentially enhancing its brand reputation and market share. As of November the competitive trends in the hip implants market are increasingly defined by digitalization, sustainability, and the integration of advanced technologies such as AI. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing product offerings. The shift from price-based competition to a focus on technological advancement and supply chain reliability is becoming evident. Companies that can effectively leverage these trends are likely to emerge as leaders in the evolving market, emphasizing the importance of innovation and adaptability in maintaining competitive differentiation. ## Recent News & Developments The France Hip Implants Market has recently witnessed significant developments. In September 2023, Zimmer Biomet announced the launch of a new line of hip implants designed using advanced materials for increased durability and patient comfort. Following this, in August 2023, Stryker introduced an innovative surgical technique aimed at reducing recovery times post-hip replacement surgeries. Additionally, Medtronic has been actively expanding its portfolio in this sector, focusing on minimally invasive solutions, a trend that has gained traction in France's healthcare landscape. The market has also seen considerable growth as the demand for hip implants increases due to the rising incidence of hip-related disorders among the aging population in France. Recent reports indicate that the valuation of the France Hip Implants Market is expected to grow steadily over the next few years, driven by advancements in technology and an increasing willingness among patients to undergo surgical interventions. In terms of mergers and acquisitions, no substantial news has emerged recently regarding the companies of interest in the France Hip Implants Market such as B. Braun Melsungen, Ottobock, and Wright Medical. Over the past two to three years, various product recalls, and regulatory approvals have played a role in shaping the landscape, highlighting the importance of compliance and innovation within the industry. ## Report Scope | MARKET SIZE 2024 | 610.68(USD Million) | | --- | --- | | MARKET SIZE 2025 | 632.42(USD Million) | | MARKET SIZE 2035 | 897.32(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.56% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Johnson & Johnson (US), Stryker Corporation (US), Zimmer Biomet (US), Smith & Nephew (GB), DePuy Synthes (US), Medtronic (US), B. Braun Melsungen AG (DE), Exactech (US), Wright Medical Group N.V. (NL) | | Segments Covered | Product, End-User, Material | | Key Market Opportunities | Adoption of advanced materials and minimally invasive techniques in the hip implants market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the hip implants market. | | Countries Covered | France | ## Frequently Asked Questions **Q: What is the current valuation of the hip implants market in France as of 2024?** A: The overall market valuation was $610.68 Million in 2024. **Q: What is the projected market valuation for hip implants in France by 2035?** A: The projected valuation for 2035 is $897.32 Million. **Q: What is the expected CAGR for the France hip implants market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during this period is 3.56%. **Q: Which companies are the key players in the France hip implants market?** A: Key players include Johnson & Johnson, Stryker Corporation, Zimmer Biomet, Smith & Nephew, DePuy Synthes, Medtronic, B. Braun Melsungen AG, Exactech, and Wright Medical Group N.V. **Q: What were the total hip implants sales figures in France for 2024?** A: Total hip implants sales figures were between $300.0 Million and $450.0 Million in 2024. **Q: How do the sales of fixed-bearing hip implants compare to mobile-bearing hip implants in France?** A: Sales for fixed-bearing hip implants ranged from $150.0 Million to $220.0 Million, whereas mobile-bearing hip implants ranged from $80.0 Million to $120.0 Million in 2024. **Q: What is the market size for partial hip implants in France as of 2024?** A: The market size for partial hip implants was between $40.0 Million and $60.0 Million in 2024. **Q: What segment had the highest sales in the France hip implants market in 2024?** A: The segment with the highest sales was total hip implants, with figures reaching up to $450.0 Million. **Q: What is the expected growth trend for the hip resurfacing implants segment in France?** A: The hip resurfacing implants segment is projected to grow, with sales figures between $20.0 Million and $30.0 Million in 2024. **Q: Which end-user segment is anticipated to dominate the France hip implants market?** A: The hospitals segment is anticipated to dominate, with sales figures ranging from $244.27 Million to $353.12 Million in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/france-hip-implants-market-51119*